Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Single-Handed Suturing Medical Device Developed By Mellon Medical


Medical Device

The Switch medical device has a range of applications, from stitching-up blood vessels to closing incisions made in the skin, and could save surgeons considerable time in the operating room.

Tweetables from this article:

Tweet: Mellon Medical's Switch #medicaldevice requires only a single hand to operate http://ctt.ec/FwI3h+ Mellon Medical's Switch medical device requires only a single hand to operate.

Share this!

October 5, 2016 | by Sarah Hand, M.Sc.

Closing a patient up after surgery is one of the most simple, yet time-consuming tasks performed by surgeons. Dutch medical device company, Mellon Medical, has set out to make this laborious process more efficient by developing their new suturing device, Switch, which requires only one hand to operate.

The Switch medical device has a range of applications, from stitching-up blood vessels to closing incisions made in the skin, and could save surgeons considerable time in the operating room. While the first iteration of this suturing medical device is 8 cm long and indicated for use during kidney transplants, peripheral bypass procedures and carotid artery surgery, the company plans to eventually release multiple sizes of the tool meant to perform different functions.

The medical device is designed to look like a pair of bent tweezers with a small needle and attached suture positioned directly at the tip of the Switch. With every manipulation of the tweezers, the needle is passed from one point to the other.

As the Switch requires only a single hand to operate, a surgeon’s non-dominant hand can be freed-up to perform other tasks such as presenting the tissue. Since the needle and attached suture are passed linearly between the tweezer tips, the surgeon does not need to focus on catching the needle as it passes through the tissue.

The result is a much more efficient way of suturing in the operating room. According to a press release issued by Mellon, the Switch is two times faster than conventional suturing methods.

As yet, the medical device is not approved by regulators, but Mellon plans to apply for both CE mark and US Food and Drug Administration (FDA) approval in the next several years. Their initial launch is set to be focused on vascular surgery but Mellon says the technology can be applied to a number of other disciplines, including neurosurgery, urology and gynecology.

Keywords: Medical Device, Surgery, FDA


Share this with your colleagues!

Lavazza Acquires Controlling Stake in Canada’s Kicking Horse Coffee

May 26, 2017 - Italian coffee company Lavazza, has secured an 80 percent equity stake in Canadian organic and fair-trade coffee company Kicking Horse Coffee, in a deal worth CAD$215 million.

Featured In: Food News

FDA First: Keytruda Approved for Cancer Treatment Based on Biomarker Alone

May 25, 2017 - For the first time, the FDA has approved a cancer treatment for solid tumors based on the presence of a biomarker, as opposed to specifying a tissue of origin.

Featured In: Biotech News

One Year of Medically Assisted Dying in Canada

May 25, 2017 - In June of 2016, the federal government of Canada passed legislation to legalize medically assisted dying.

Featured In: Life Science News


Top 5 Most Impactful Tweets in Life Sciences During the Last Week


EU IVD Regulation: Top Five Changes for Medical Device Manufacturers to Consider

Thermal Processing Systems for the Food Industry: A Guide to Selecting Thermal Equipment and Technology

Rare Disease & Orphan Drug Development: Cost-Efficient Trial Design to Minimize Cash Burn

eTMF Workflows: Active eTMF to Improve the Quality of Clinical Trials

Copyright © 2016-2017 Honeycomb Worldwide Inc.